Moderna
MRNA
#277
Rank
โ‚น7.772 T
Marketcap
โ‚น19,208
Share price
4.00%
Change (1 day)
797.75%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - P/B ratio

P/B ratio as of November 2026 : 11.9

According to Moderna 's latest financial reports the company has a price-to-book ratio of 36.4946.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Moderna - P/B ratio (from 2018 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-311.39-1.6%
2024-12-311.42-48.24%
2023-12-312.74-24.15%
2022-12-313.61-50.43%
2021-12-317.28-54.9%
2020-12-3116.1188.09%
2019-12-315.6070.78%
2018-12-313.28
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.89-33.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.60-36.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
7.80-34.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
8.18-31.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-0.0229-100.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
5.49-53.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
13.2 10.99%๐Ÿ‡บ๐Ÿ‡ธ USA